Genomics in Cancer Care Market 2027 by Product and Service, Technology, Application, End User and Geography | The Insight Partners

Genomics in Cancer Care Market to 2027 - Global Analysis and Forecasts By Product and Service (Instruments, Consumables, Service); Technology (Gene Sequencing, PCR, Microarray Nucleic Acid Extraction and Purification, Others); Application (Diagnostic, Drug Delivery, Precision Medicine, Research); End User (Hospitals, Diagnostics Laboratories, Academic and Research Institutes); and Geography

Report Code: TIPRE00006958 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Genomics is study of gene and other molecular components that helps in the characterizing the genetic properties of cells and their functions. The genomics is the widely used biotechnological tool that has shown various benefits in the clinical and medical sector. The use of the genomics has allowed to study cancer and its heritance more efficiently and conveniently in the medical sector. The use of genomics has resulted into innovations of various treatments and preventive measures for cancer.

MARKET DYNAMICS

The genomics in cancer care market is estimated to grow owing to the factors such as increasing incidences of cancer, rapid technological innovations & development in the field of genomics and increasing healthcare facilities. The growth of the market during the forecast period is anticipated due to the growth opportunities such as increasing developments in the healthcare industries, increasing awareness about the advancements of cancer and precision medicine and others.

MARKET SCOPE

The "Global Genomics in Cancer Care Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of genomics in cancer care market with detailed market segmentation by product & service, technology, application, end user and geography. The global genomics in cancer care market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading genomics in cancer care market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global genomics in cancer care market is segmented on the basis of product & service, technology, application, and end user. Based on the product & service the market is segmented as instruments, consumables, and service. On the basis of technology the market is segmented as gene sequencing, PCR, microarray nucleic acid extraction and purification, and others. On the basis of application segment the market is classified as diagnostic, drug delivery, precision medicine, and research. And on the basis of end user the market is segmented as hospitals, diagnostics laboratories, and academic & research institutes.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global genomics in cancer care market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genomics in cancer care market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting genomics in cancer care market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the genomics in cancer care market in these regions.

MARKET PLAYERS


The reports cover key developments in the genomics in cancer care market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from genomics in cancer care market are anticipated to lucrative growth opportunities in the future with the rising demand for genomics in cancer care market in the global market. Below mentioned is the list of few companies engaged in the genomics in cancer care market.

The report also includes the profiles of key genomics in cancer care market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  Illumina Inc.
  •  Agilent Technologies, Inc.
  •  Thermo Fisher Scientific Inc.
  •  PerkinElmer, Inc.
  •  QIAGEN N.V.
  •  Merck KGaA
  •  BGI
  •  F. Hoffmann-La Roche AG
  •  Bio-Rad Laboratories, Inc.
  •  GE Healthcare
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genomics In Cancer Care Market - By Product and Service
1.3.2 Genomics In Cancer Care Market - By Technology
1.3.3 Genomics In Cancer Care Market - By Application
1.3.4 Genomics In Cancer Care Market - By End User
1.3.5 Genomics In Cancer Care Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GENOMICS IN CANCER CARE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENOMICS IN CANCER CARE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENOMICS IN CANCER CARE MARKET - GLOBAL MARKET ANALYSIS
6.1. GENOMICS IN CANCER CARE - GLOBAL MARKET OVERVIEW
6.2. GENOMICS IN CANCER CARE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT AND SERVICE
7.1. OVERVIEW
7.2. PRODUCT AND SERVICE MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
7.5. SERVICE
7.5.1. Overview
7.5.2. Service Market Forecast and Analysis
8. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. GENE SEQUENCING
8.3.1. Overview
8.3.2. Gene Sequencing Market Forecast and Analysis
8.4. PCR
8.4.1. Overview
8.4.2. PCR Market Forecast and Analysis
8.5. MICROARRAY NUCLEIC ACID EXTRACTION AND PURIFICATION
8.5.1. Overview
8.5.2. Microarray Nucleic Acid Extraction and Purification Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTIC
9.3.1. Overview
9.3.2. Diagnostic Market Forecast and Analysis
9.4. DRUG DELIVERY
9.4.1. Overview
9.4.2. Drug Delivery Market Forecast and Analysis
9.5. PRECISION MEDICINE
9.5.1. Overview
9.5.2. Precision Medicine Market Forecast and Analysis
9.6. RESEARCH
9.6.1. Overview
9.6.2. Research Market Forecast and Analysis
10. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. DIAGNOSTICS LABORATORIES
10.4.1. Overview
10.4.2. Diagnostics Laboratories Market Forecast and Analysis
10.5. ACADEMIC AND RESEARCH INSTITUTES
10.5.1. Overview
10.5.2. Academic and Research Institutes Market Forecast and Analysis
11. GENOMICS IN CANCER CARE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Genomics In Cancer Care Market Overview
11.1.2 North America Genomics In Cancer Care Market Forecasts and Analysis
11.1.3 North America Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.1.4 North America Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.1.5 North America Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.1.6 North America Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.1.7 North America Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.1.7.1 United States Genomics In Cancer Care Market
11.1.7.1.1 United States Genomics In Cancer Care Market by Product and Service
11.1.7.1.2 United States Genomics In Cancer Care Market by Technology
11.1.7.1.3 United States Genomics In Cancer Care Market by Application
11.1.7.1.4 United States Genomics In Cancer Care Market by End User
11.1.7.2 Canada Genomics In Cancer Care Market
11.1.7.2.1 Canada Genomics In Cancer Care Market by Product and Service
11.1.7.2.2 Canada Genomics In Cancer Care Market by Technology
11.1.7.2.3 Canada Genomics In Cancer Care Market by Application
11.1.7.2.4 Canada Genomics In Cancer Care Market by End User
11.1.7.3 Mexico Genomics In Cancer Care Market
11.1.7.3.1 Mexico Genomics In Cancer Care Market by Product and Service
11.1.7.3.2 Mexico Genomics In Cancer Care Market by Technology
11.1.7.3.3 Mexico Genomics In Cancer Care Market by Application
11.1.7.3.4 Mexico Genomics In Cancer Care Market by End User
11.2. EUROPE
11.2.1 Europe Genomics In Cancer Care Market Overview
11.2.2 Europe Genomics In Cancer Care Market Forecasts and Analysis
11.2.3 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.2.4 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.2.5 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.2.6 Europe Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.2.7 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Genomics In Cancer Care Market
11.2.7.1.1 Germany Genomics In Cancer Care Market by Product and Service
11.2.7.1.2 Germany Genomics In Cancer Care Market by Technology
11.2.7.1.3 Germany Genomics In Cancer Care Market by Application
11.2.7.1.4 Germany Genomics In Cancer Care Market by End User
11.2.7.2 France Genomics In Cancer Care Market
11.2.7.2.1 France Genomics In Cancer Care Market by Product and Service
11.2.7.2.2 France Genomics In Cancer Care Market by Technology
11.2.7.2.3 France Genomics In Cancer Care Market by Application
11.2.7.2.4 France Genomics In Cancer Care Market by End User
11.2.7.3 Italy Genomics In Cancer Care Market
11.2.7.3.1 Italy Genomics In Cancer Care Market by Product and Service
11.2.7.3.2 Italy Genomics In Cancer Care Market by Technology
11.2.7.3.3 Italy Genomics In Cancer Care Market by Application
11.2.7.3.4 Italy Genomics In Cancer Care Market by End User
11.2.7.4 Spain Genomics In Cancer Care Market
11.2.7.4.1 Spain Genomics In Cancer Care Market by Product and Service
11.2.7.4.2 Spain Genomics In Cancer Care Market by Technology
11.2.7.4.3 Spain Genomics In Cancer Care Market by Application
11.2.7.4.4 Spain Genomics In Cancer Care Market by End User
11.2.7.5 United Kingdom Genomics In Cancer Care Market
11.2.7.5.1 United Kingdom Genomics In Cancer Care Market by Product and Service
11.2.7.5.2 United Kingdom Genomics In Cancer Care Market by Technology
11.2.7.5.3 United Kingdom Genomics In Cancer Care Market by Application
11.2.7.5.4 United Kingdom Genomics In Cancer Care Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Genomics In Cancer Care Market Overview
11.3.2 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis
11.3.3 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.3.4 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Genomics In Cancer Care Market
11.3.7.1.1 Australia Genomics In Cancer Care Market by Product and Service
11.3.7.1.2 Australia Genomics In Cancer Care Market by Technology
11.3.7.1.3 Australia Genomics In Cancer Care Market by Application
11.3.7.1.4 Australia Genomics In Cancer Care Market by End User
11.3.7.2 China Genomics In Cancer Care Market
11.3.7.2.1 China Genomics In Cancer Care Market by Product and Service
11.3.7.2.2 China Genomics In Cancer Care Market by Technology
11.3.7.2.3 China Genomics In Cancer Care Market by Application
11.3.7.2.4 China Genomics In Cancer Care Market by End User
11.3.7.3 India Genomics In Cancer Care Market
11.3.7.3.1 India Genomics In Cancer Care Market by Product and Service
11.3.7.3.2 India Genomics In Cancer Care Market by Technology
11.3.7.3.3 India Genomics In Cancer Care Market by Application
11.3.7.3.4 India Genomics In Cancer Care Market by End User
11.3.7.4 Japan Genomics In Cancer Care Market
11.3.7.4.1 Japan Genomics In Cancer Care Market by Product and Service
11.3.7.4.2 Japan Genomics In Cancer Care Market by Technology
11.3.7.4.3 Japan Genomics In Cancer Care Market by Application
11.3.7.4.4 Japan Genomics In Cancer Care Market by End User
11.3.7.5 South Korea Genomics In Cancer Care Market
11.3.7.5.1 South Korea Genomics In Cancer Care Market by Product and Service
11.3.7.5.2 South Korea Genomics In Cancer Care Market by Technology
11.3.7.5.3 South Korea Genomics In Cancer Care Market by Application
11.3.7.5.4 South Korea Genomics In Cancer Care Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Genomics In Cancer Care Market Overview
11.4.2 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis
11.4.3 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.4.4 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Genomics In Cancer Care Market
11.4.7.1.1 South Africa Genomics In Cancer Care Market by Product and Service
11.4.7.1.2 South Africa Genomics In Cancer Care Market by Technology
11.4.7.1.3 South Africa Genomics In Cancer Care Market by Application
11.4.7.1.4 South Africa Genomics In Cancer Care Market by End User
11.4.7.2 Saudi Arabia Genomics In Cancer Care Market
11.4.7.2.1 Saudi Arabia Genomics In Cancer Care Market by Product and Service
11.4.7.2.2 Saudi Arabia Genomics In Cancer Care Market by Technology
11.4.7.2.3 Saudi Arabia Genomics In Cancer Care Market by Application
11.4.7.2.4 Saudi Arabia Genomics In Cancer Care Market by End User
11.4.7.3 U.A.E Genomics In Cancer Care Market
11.4.7.3.1 U.A.E Genomics In Cancer Care Market by Product and Service
11.4.7.3.2 U.A.E Genomics In Cancer Care Market by Technology
11.4.7.3.3 U.A.E Genomics In Cancer Care Market by Application
11.4.7.3.4 U.A.E Genomics In Cancer Care Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Genomics In Cancer Care Market Overview
11.5.2 South and Central America Genomics In Cancer Care Market Forecasts and Analysis
11.5.3 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.5.4 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.5.6 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.5.7 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Genomics In Cancer Care Market
11.5.7.1.1 Brazil Genomics In Cancer Care Market by Product and Service
11.5.7.1.2 Brazil Genomics In Cancer Care Market by Technology
11.5.7.1.3 Brazil Genomics In Cancer Care Market by Application
11.5.7.1.4 Brazil Genomics In Cancer Care Market by End User
11.5.7.2 Argentina Genomics In Cancer Care Market
11.5.7.2.1 Argentina Genomics In Cancer Care Market by Product and Service
11.5.7.2.2 Argentina Genomics In Cancer Care Market by Technology
11.5.7.2.3 Argentina Genomics In Cancer Care Market by Application
11.5.7.2.4 Argentina Genomics In Cancer Care Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. GENOMICS IN CANCER CARE MARKET, KEY COMPANY PROFILES
13.1. ILLUMINA INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AGILENT TECHNOLOGIES, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. THERMO FISHER SCIENTIFIC INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PERKINELMER, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. QIAGEN N.V.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERCK KGAA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BGI
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. F. HOFFMANN LA ROCHE AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIO RAD LABORATORIES, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. GE HEALTHCARE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Illumina Inc.
2. Agilent Technologies, Inc.
3. Thermo Fisher Scientific Inc.
4. PerkinElmer, Inc.
5. QIAGEN N.V.
6. Merck KGaA
7. BGI
8. F. Hoffmann-La Roche AG
9. Bio-Rad Laboratories, Inc.
10. GE Healthcare